Table VI.
A sample of unmapped concepts showing the categorization of reasons that the codes were not mapped. There are five categories: 1) A- no analyte, 2) M – meaning is not clear, 3) I – internal use, 4) O – overly specific method and 5) N – narrative result
| ARUP | Re aso n |
Intermountain | Re aso n |
Regenstrief | Re aso n |
|---|---|---|---|---|---|
| ACYLCARNITINE PROFILE |
A | Comments Lab Result, Qualitative~for GFR |
N | SPECIMEN DESCRIPTION |
N |
| NBC14:1_C16 NBS RATIO |
A | Report Status, Qualitative (RPT) |
I | Final | N |
| NB GLU_CIT NBS RATIO |
A | Comments | N | LDL MESSAGE | M |
| NB METHIONE | A | Cerebrospinal Screen, Cerebrospinal Fluid Qualitative |
A | Initial Specimen? | I |
| NB C12-OH | A | Method of Release | I | Other | M |
| HIRLU | M | Comments Lab Result, Qualitative (CMRSS) |
N | Xanthochromic | A |
| ESTIMATED DUE DATE |
I | Specimen Number, Serum Quantitative |
I | Engraft Study Post TX | N |
| DETERMINED BY: | I | Hold Clot (order only) |
A | SCL T&B lymph. | A |
| VT FINAL DIAGNOSIS |
I | Comments Lab Result, Qualitative (CVAR) |
N | BB Physician | M |
| ENDOCERVICAL COMPONENT |
A | Numbers/Type of Containers: |
I | CSF-XANTHCHROMI A |
A |
| UA CULTURE IF ? | I | Comments Lab Result, Qualitative (CPSAF) |
N | DETERMINED BY: | I |
| ANTI- B | A | Comments Lab Result, Qualitative (CMNT) |
N | Allergen Scoring Chart | I |
| META UF INTERP | N | Antigen Type | A | DIABETIC | M |
| CS ADD REQUEST | I | RAST Interpretation, Serum Narrative |
N | TRICH SCREEN SOURCE |
A |
| DOCTOR REVIEW - PT PCR |
N | Comments Lab Result, Qualitative (CFVL) |
N | Miscellaneous CPT | I |
| HEP B CORE AB S/C RATIO |
A | Result Date, Quantitative |
A | Interp Gliadin/Gluten IgA |
N |
| SP CLINICAL HISTORY |
A | MoM for Nuchal Translucency |
A | HSV 1,2 DNA Specimen Type |
A |
| OPIATES, NUMERIC INSTRUMENT |
O | Phone orders | I | Interpretation | N |
| BARBITURATE, NUMERIC INSTRMNT |
O | Comments Lab Result, Qualitative (CFTA) |
N | LS Interpretation | N |
| INTERPRETATION /SPECIAL CHEM |
N | Chronic Lymphocytic Leukemia Panel, Blood Qualitative Flow Cytometry~USE CODE FLOWLL |
A | PRE TRANS B/P | I |
| VT TISSUE DESCRIP-CYTOL OGY |
N | Insulin Sensitivity Index, Serum or Plasma Quantitative |
A | HLA-DR DQ low res | O |
| VT MINI DIAGNOSIS |
N | Comments Lab Result, Qualitative~Used with CLSW |
N | PHOSPHATIDLSER IGG |
A |
| ANATOMIC PATHOLOGY TRACKING T |
I | Alpha-Beta % | A | Seq. HLA-B Interp | N |
| SP COMMENTS | N | Pathologist Interpretation, Qualitative~INAC TIVE 8/14/2007 |
N | Cryptococcus AG BLD Interp |
N |